Trending...
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience - 322
- New Slotozilla Project Explores What Happens When the World Goes Silent - 260
- Ventura College Launches County's First Speech-Language Pathology Assistant Program - 244
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Homology Medicines, Inc.. ("Homology" or "the Company") (NASDAQ: FIXX) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Homology is the subject of a report published by Mariner Research on July 21, 2020. The report questions the efficacy of the Company's lead product candidate, HMI-102. The report alleges that the company concealed efficacy information and predicted that the drug would not continue to commercialization. Based on this report, shares of Homology dropped by more than 10% on July 24, 2020.
More on The Californer
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Homology is the subject of a report published by Mariner Research on July 21, 2020. The report questions the efficacy of the Company's lead product candidate, HMI-102. The report alleges that the company concealed efficacy information and predicted that the drug would not continue to commercialization. Based on this report, shares of Homology dropped by more than 10% on July 24, 2020.
More on The Californer
- California: Californication of AI? Golden State is #1 in AI, and the birthplace of modern tech, so yeah — be quiet, Ted Cruz
- Premieres of 10th Annual NY Dog Film Festival & 8th Annual NY Cat Film Festival on Sunday, October 26, 2025 to Benefit Animal Lighthouse Rescue
- Inwebify Announces Launch of Scalable and Redundant Cloud Hosting Platform
- $20 Price Target in Noble Capital Research Report as Deal is Signed for NFL Yearbook Advertising Across 25 Stadiums for AI Powered Sports Leader $SEGG
- Zenni Optical Hosts Expert Panel Following the Launch of EyeQLenz™ with Zenni ID Guard™ Featuring Technology Experts Cybersecurity Girl, Judner Aura and Amber Mac
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Filed Under: Business
0 Comments
Latest on The Californer
- Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges
- TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
- AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
- JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
- TOM HAUSKEN: The Space Between
- California: Governor Newsom announces appointments 9.17.25
- Marketing Maven Ranked Top 10 PR Firm in Los Angeles by O'Dwyer's in 2025 Rankings Report
- California Lutheran University Receives Over $2.9 Million in Grant Funding
- Nationwide Boiler Supplies In-Stock 200K lb/hr Ultra Low NOx Boiler Package for Recovery Efforts i
- Ventura College Foundation Accepting Scholarship Applications for 2026-27 School Year
- C3.ai, Inc. (AI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- California: Governor Newsom proclaims Constitution Day and Citizenship Day
- California: Governor Newsom signs legislation 9.17.25
- New Leadership and Renovations Usher in Next Chapter for Sunrise Manor
- Following Trump's politicization of CDC, West Coast states issue unified vaccine recommendations — California breaks from future federal guidance with new law
- Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections
- Silva Construction Weighs In on the Most Popular Home Design Trends for 2026
- Geeks5g Creative Marketing: The Powerhouse Behind Business Growth
- Wise Business Plans Now Serves Entrepreneurs in Los Angeles with Tailored Business Plan Writing
- Proposition 1 continues delivering support for vulnerable homeless populations in California